Logo image
Aggregation and secondary loop structure of oligonucleotides do not determine their ability to inhibit TLR9
Journal article   Peer reviewed

Aggregation and secondary loop structure of oligonucleotides do not determine their ability to inhibit TLR9

Robert F Ashman, J Adam Goeken and Petar S Lenert
International immunopharmacology, Vol.11(8), pp.1032-1037
08/2011
DOI: 10.1016/j.intimp.2011.02.023
PMCID: PMC3119753
PMID: 21376154

View Online

Abstract

Toll-like receptor 9 (TLR9) is an endosomal DNA sensor that warns us of the presence of infectious danger and triggers a rapid pro-inflammatory response in dendritic cells, macrophages, and B cells. The consequences of uncontrolled TLR9 activation can be detrimental for the host, contributing to the pathogenesis of bacterial septic shock or autoimmune diseases, such as systemic lupus erythematosus. Therefore, we need to develop TLR9 antagonists. We and others have created inhibitory oligonucleotides (INH-ODN) that are capable of sequence-dependent inhibition of TLR9-induced activation in both human and mouse cells. However, it is not clear whether marked differences in INH-ODN activity related to base sequence derived from polymerization of INH-ODNs or their ability to complex with stimulatory CpG-oligonucleotides (ST-ODN). Furthermore, the 5' end of INH-ODNs may assume a particular loop configuration that may be needed for binding to a critical site on TLR9. Here, we show that 1) G-tetrads required for ODN stacking were compatible with INH-ODN activity but were not necessary; 2) there was no relationship between activity and self-association at endosomal pH; 3) there was no evidence for direct binding between ST-ODNs and INH-ODNs; 4) when a 3G sequence was disrupted, despite a preserved stem-loop formation, INH-ODN activity was abolished. These results support the conclusion that certain features of the primary linear sequence are critical for TLR9 inhibition, but changes in secondary structure or in ODN aggregation are irrelevant.
Cell Line Oligonucleotides - chemistry Toll-Like Receptor 9 - antagonists & inhibitors Humans Oligodeoxyribonucleotides - chemistry B-Lymphocytes Polymerization Structure-Activity Relationship Animals Oligonucleotides - pharmacology Base Sequence Protein Binding Mice Oligodeoxyribonucleotides - pharmacology Toll-Like Receptor 9 - metabolism Binding Sites

Details

Metrics

Logo image